The analyses of the co-expression of immunomodulatory molecules PD-1, PD-L1, ICOS, LAG3, TIM3, and IDO showed heterogeneous populations of immune and tumor cells (Figures 6C and S6D). This evidence concerns the gene HAVCR2 and neoplasm.